Comparison Chart Spero Therapeutics, Inc.

Stocks

SPRO

US84833T1034

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 12:25:35 2026-07-20 EDT			5-day change	1st Jan Change
1.445 ^USD	-8.54%		-33.49%	-37.77%

07-15	Innovent Biologics Shares Surge on Spero Deal That Could Be Worth $1.1 Billion	DJ
07-14	Innovent Biologics, Inc. and Spero Therapeutics, Inc. Announce Exclusive License Agreement for IBI355, Phase 2-Ready Third-Generation Anti-CD40L Antibody	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	SPERO THERAPEUTICS, INC.	Bio Therapeutic Drugs	-8.23%	-33.49%	-37.77%	-37.50%	-90.16%	91.48M